Colgate-Palmolive Company [CL] stock is down -1.10 while the S&P 500 has risen 0.01% on Tuesday, 12/01/20. While at the time of this article, CL ATR is sitting at 1.45, with the beta value at 0.57. This stock’s volatility for the past week remained at 1.36%, while it was 1.74% for the past 30-day period. CL has fallen -$0.95 from the previous closing price of $86.26 on volume of 1.18 million shares.
On 19, November 2020, Colgate Laboratory Tests Show Toothpaste and Mouthwash Neutralize 99.9% of the Virus That Causes COVID-19. According to news published on Yahoo Finance, Clinical Research Program Underway To Validate Potential of Oral Health Products to Slow Spread of the Virus.
Analyst Birdseye View:
The most recent analyst activity for Colgate-Palmolive Company [NYSE:CL] stock was on March 27, 2020, when it was Upgrade with a Buy rating from SunTrust. Before that, on July 22, 2020, Morgan Stanley Recapitulated an Equal-weight rating and elevated its amount target to $78. On March 27, 2020, Stifel Upgrade a Buy rating and plunged its price target on this stock from $80 to $72. On March 23, 2020, Morgan Stanley Upgrade an Overweight rating and increased its price target to $72. On March 20, 2020, BofA/Merrill Upgrade a Buy rating. On February 03, 2020, RBC Capital Mkts Upgrade an Outperform rating. On February 03, 2020, Atlantic Equities Upgrade an Overweight rating. On December 19, 2019, BofA/Merrill Downgrade a Neutral rating and improved its amount target to $74.
In the past 52 weeks of trading, this stock has oscillated between a low of $58.49 and a peak of $86.41. Right now, the middling Wall Street analyst 12-month amount mark is $85.00. At the most recent market close, shares of Colgate-Palmolive Company [NYSE:CL] were valued at $85.31. According to the average price forecast, investors can expect a potential return of 1.67%.
Colgate-Palmolive Company [NYSE:CL] most recently reported quarterly sales of 4.15 billion, which represented growth of 5.70%. This publicly-traded organization’s revenue is $457,522 per employee, while its income is $69,009 per employee. This company’s Gross Margin is currently 60.60%, its Operating Margin is 23.80%, its Pretax Margin is +21.03, and its Net Margin is +15.08. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 17.41, 31,560.00, 48.22 and 33.35 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 98.64 and the whole liability to whole assets at 56.43. It shows enduring liability to the whole principal at 90.98 and enduring liability to assets at 0.52 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 85.65 points at 1st support level, the second support level is making up to 85.03. But as of 1st resistance point, this stock is sitting at 86.61 and at 86.95 for 2nd resistance point.
Colgate-Palmolive Company [CL] reported its earnings at $0.79 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.7/share signifying the difference of 0.09 and 12.90% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were $0.74 calling estimates for $0.69/share with the difference of 0.05 depicting the surprise of 7.20%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Colgate-Palmolive Company [NYSE:CL] is 1.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.22. Now if looking for a valuation of this stock’s amount to sales ratio it’s 3.78, it’s amount to book ratio is 502.89 and showing 27.54 of P/E (TTM) ratio.
The most recent insider trade was by Tsourapas Panagiotis, Grp Pres, LatAm,AsiaPac&AF/Eus, and it was the sale of 11714.0 shares on Nov 18. Wallace Noel R., the Chairman, President & CEO, completed a sale of 21446.0 shares on Nov 17. On Nov 16, Tsourapas Panagiotis, Grp Pres, LatAm,AsiaPac&AF/Eus, completed a sale of 15000.0 shares.